Nordson (NDSN) official guidance

Sales are now expected to be in the range of $3 billion and $35 million to $3 billion and $75 million, and adjusted earnings to be in the range of $11.80-$12 per diluted share, putting us on the high end of our previously communicated average growth algorithm.

Sales are now expected to be in the range of $3,035 to $3,075 million and adjusted earnings to be in the range of $11.80 to $12.00 per diluted share.

Based on backlog and order entry momentum, we expect the strong sales of the first nine months to continue through the fourth quarter.

We now expect our full-year tax rate to be in the range of 18%-19% on an adjusted basis, which is slightly better than our previous annual guidance range for fiscal 2026.

Third quarter adjusted earnings are forecasted to be in the range of $2.95-$3.15 per diluted share.

These trends position the company to deliver third quarter fiscal 2026 sales in the range of $760 million-$790 million.

We still project our full year tax rate to be at the lower end of our initial guidance range of 18.5%-19.5%.

Second quarter adjusted earnings are forecasted to be in the range of $2.70-$2.90 per diluted share.

The 3% growth was a slower start than we expected for the segment, but we remain confident in the mid-single-digit outlook through the year.

These trends position the company to deliver second quarter fiscal 2026 sales in the range of $710 million-$740 million.

The comps get a little bit difficult, but yet, based on what we can see in terms of backlog and order entry momentum, we feel still good about this year, this business being north of its long-term targets of mid-single digits.

You know, what we feel, the headline really is we return to growth with IPS. You know, we posted a 3% organic growth in the quarter. Expect that, you know, we will do so in the rest of the year.

We enter fiscal 2026 with approximately $600 million in backlog, up 5% from the prior year end, excluding backlog associated with the divested business.

For modeling purposes, in fiscal 2026, assume an estimated effective tax rate of 18.5%-19.5%, capital expenditures of approximately $55 million-$65 million, and interest expense of approximately $85 million-$95 million.

As you will see on slide 15, first quarter fiscal 2026 sales are forecasted in the range of $630 million-$670 million, and adjusted earnings in the range of $2.25-$2.45 per diluted shares.

Full year 2026 adjusted earnings are forecasted to be in the range of 6%-12% growth per diluted share, with a midpoint of 9% adjusted earnings growth also progressing well toward our annual adjusted EPS growth algorithm.

In 2029, when we look back on our financial performance for that period, we expect to deliver an average annual growth of 6%-8% in revenue balanced between organic and acquisitive growth, and 10%-12% in adjusted EPS growth.

For modeling purposes, in fiscal 2026, assume an estimated effective tax rate of 18.5%-19.5%, capital expenditures of approximately $55 million-$65 million, and interest expense of approximately $85 million-$95 million.

As you will see on slide 15, first quarter fiscal 2026 sales are forecasted in the range of $630 million-$670 million, and adjusted earnings in the range of $2.25-$2.45 per diluted shares.

Overall, we expect the IPS segment to return to more normal growth rates of low single digits.